DrugMapper
  • Browse
    • Therapeutic Area
      • CANCER (51)
      • CARDIOVASCULAR (45)
      • DENTISTRY (2)
      • DERMATOLOGY (31)
      • DIABETES DRUGS & ENDOCRINOLOGY (61)
      • EMERGENCY MEDICINE (3)
      • ENT (5)
      • EYE (23)
      • GASTROINTESTINAL (29)
      • HEMATOLOGY (23)
      • MUSCULOSKELETAL (28)
      • NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
      • PEDIATRICS (27)
      • PHARMACOLOGY (8)
      • PREGNANCY AND GYNECOLOGY (30)
      • RESPIRATORY (42)
      • RHEUMATOLOGY (19)
      • OTHER (1482)
    • Therapeutic Indication
    • Adverse Reaction (System Organ Classification)
    • Mechanism of Action
    • Primary Target
    • Target Level
      • Level 1
      • Level 2
      • Level 3
      • Level 4
      • Level 5
      • Level 6
    • Active Pharmaceutical Ingredients (APIs)
    • Small Molecules
    • ProDrugs
    • Antibodies
    • CNS drugs
    • Metabolites
  • Search
      Therapeutic Indication Adverse Reaction (System Organ Classification)
      Mechanism of Action Target Sequence
      Chemical Structure Physicochemical Properties
  • Analyze

      Networks

    • Chemical Similarity
    • Scaffold Similarity
    • KNIME workflow
  • Downloads
      Web services Bulk Downloads
  • About
      DrugMapper FAQs Data Sources Contact Us

VEPOLOXAMER

Search structure
Synonyms:
Kolliphor p 188
Kolliphor p188
Lutrol f 68
Lutrol f68
MST-188
Pluracare f 68
Pluronic f-68
Pluronic f68
Pluronic f68lf
Poloxalkol
Poloxamer 188
Poloxamer-188
Poloxamer 188lf
Polykol
Vepoloxamer
Status: Phase 3
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: LQA7B6G8JG

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Anemia, Sickle Cell 3 D000755 ClinicalTrials
Heart Failure 2 D006333 ClinicalTrials
Ischemia 2 D007511 ClinicalTrials
Kidney Diseases 1 D007674 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3137355
FDA SRS LQA7B6G8JG
CONTENTS
  • Structure
  • Indications
  • Cross References
×
70